Tadalafil/Oxytocin/PT-141 Nasal Spray

This compounded nasal spray combines tadalafil, oxytocin, and PT-141 in a 50mg/600IU/2.5mg per mL formulation. The product is positioned as a provider-reviewed sexual wellness option that brings together three distinct research pathways: PDE5 inhibition through tadalafil, intimacy and arousal signaling through oxytocin, and melanocortin receptor activity through PT-141. It should be evaluated as a prescription-only compounded medication, not as an over-the-counter supplement.

Tadalafil is a phosphodiesterase type 5 (PDE5) inhibitor that supports nitric-oxide mediated vasodilation. Oxytocin is a cyclic nonapeptide involved in pair bonding, social connection, and sexual response signaling. PT-141, also known as bremelanotide, is a melanocortin receptor agonist studied for centrally mediated sexual desire and arousal. The rationale for the combination is that sexual response can involve vascular, neurological, and relational signaling pathways rather than one isolated mechanism.

This compounded combination is designed for a guided sexual wellness workflow where medical history, current medications, blood pressure status, and cardiovascular history are collected before pharmacy routing. The goal is a cleaner, more convenient path for patients comparing multi-pathway sexual wellness options.